Patient-reported outcomes from STARTRK-2: a global phase II basket study of entrectinib for ROS1 fusion-positive non-small-cell lung cancer and NTRK fusion-positive solid tumours

Small Cell ◽

Solid Tumours ◽

Small Cell Lung ◽

385P Patient reported outcomes (PROs) analysis for patients with ROS1 fusion-positive (ROS1+) non-small cell lung cancer (NSCLC) receiving entrectinib in the global phase II STARTRK-2 study

Annals of Oncology ◽

10.1016/j.annonc.2020.10.379 ◽

2020 ◽

Vol 31 ◽

pp. S1391-S1392

Author(s):

F. Barlesi ◽

J. Wolf ◽

M-J. Ahn ◽

R.C. Doebele ◽

L. Paz-Ares ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

138PD_PR Patient-reported outcomes (PROs) in ALEX: A phase III study of alectinib (ALEC) vs crizotinib (CRIZ) in non-small-cell lung cancer (NSCLC)

Journal of Thoracic Oncology ◽

10.1016/s1556-0864(18)30412-x ◽

2018 ◽

Vol 13 (4) ◽

pp. S80-S81 ◽

Cited By ~ 1

Author(s):

M. Perol ◽

S. Peters ◽

N. Pavlakis ◽

E. Levchenko ◽

M. Platania ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Patient Reported ◽

Phase Iii Study

HSR21-067: What Patient-Reported Outcomes Are Being Used in Non-small Cell Lung Cancer? A Targeted Literature Review of Randomized Clinical Trials and Regulatory Labeling

Journal of the National Comprehensive Cancer Network ◽

10.6004/jnccn.2020.7726 ◽

2021 ◽

Vol 19 (3.5) ◽

pp. HSR21-067

Author(s):

Kajal Patel ◽

Soham Shukla ◽

Jennifer Hanlon ◽

Kelly Bell ◽

Laurie Eliason ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trials ◽

Literature Review ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Randomized Clinical Trials ◽

Small Cell ◽

Small Cell Lung ◽

Early Postoperative Patient-Reported Outcomes After Thoracoscopic Segmentectomy Versus Lobectomy for Small-Sized Peripheral Non-small-cell Lung Cancer

Annals of Surgical Oncology ◽

10.1245/s10434-021-10946-7 ◽

2021 ◽

Author(s):

Wei Dai ◽

Shuai Chang ◽

Cecilia Pompili ◽

Bin Qiu ◽

Xing Wei ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Postoperative Patient ◽

Are the data on quality of life and patient reported outcomes from clinical trials of metastatic non-small-cell lung cancer important?

World Journal of Clinical Oncology ◽

10.5306/wjco.v4.i4.82 ◽

2013 ◽

Vol 4 (4) ◽

pp. 82 ◽

Cited By ~ 8

Author(s):

Vera Hirsh

Keyword(s):

Quality Of Life ◽

Lung Cancer ◽

Clinical Trials ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Patient-Reported Outcomes of Chemotherapy Involving Non-Small Cell Lung Cancer: Evaluation by Questionnaires of Quality of Life Regarding Anti-Aging and Anti-Cancer Drugs

Advances in Lung Cancer ◽

10.4236/alc.2017.62002 ◽

2017 ◽

Vol 06 (02) ◽

pp. 13-35

Author(s):

Takanori Ayabe ◽

Masaki Tomita ◽

Takashi Asada ◽

Kazuyo Tsuchiya ◽

Manabu Nemoto ◽

...

Keyword(s):

Quality Of Life ◽

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Patient Reported ◽

Anti Cancer

Patient-Reported Outcomes From Patients Receiving Immunotherapy or Chemoimmunotherapy for Metastatic Non–Small-Cell Lung Cancer in Clinical Practice

Clinical Lung Cancer ◽

10.1016/j.cllc.2019.11.015 ◽

2020 ◽

Vol 21 (3) ◽

pp. 255-263.e4

Author(s):

Laurie E. Steffen McLouth ◽

Thomas W. Lycan ◽

Beverly J. Levine ◽

Jennifer Gabbard ◽

Jimmy Ruiz ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Practice ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

LBA59 First-line nivolumab (NIVO) + ipilimumab (IPI) combined with 2 cycles of platinum-based chemotherapy (chemo) vs 4 cycles of chemo in advanced non-small cell lung cancer (NSCLC): Patient-reported outcomes (PROs) from CheckMate 9LA

Annals of Oncology ◽

10.1016/j.annonc.2020.08.2292 ◽

2020 ◽

Vol 31 ◽

pp. S1187-S1188

Author(s):

M. Reck ◽

T-E. Ciuleanu ◽

M. Cobo ◽

M. Schenker ◽

B. Zurawski ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Nsclc Patient ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Platinum Based Chemotherapy ◽

Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study

The Lancet Oncology ◽

10.1016/s1470-2045(19)30519-4 ◽

2019 ◽

Vol 20 (12) ◽

pp. 1670-1680 ◽

Cited By ~ 22

Author(s):

Rina Hui ◽

Mustafa Özgüroğlu ◽

Augusto Villegas ◽

Davey Daniel ◽

David Vicente ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung ◽

Phase 3 ◽

Patient Reported ◽

Randomised Controlled

A Randomized Study of Electronic Diary versus Paper and Pencil Collection of Patient-Reported Outcomes in Patients with Non-Small Cell Lung Cancer

The Patient Patient-Centered Outcomes Research ◽

10.2165/01312067-200801020-00006 ◽

2008 ◽

Vol 1 (2) ◽

pp. 105-113 ◽

Cited By ~ 10

Author(s):

Alistair E Ring ◽

Kerry A Cheong ◽

Claire L Watkins ◽

David Meddis ◽

David Cella ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Randomized Study ◽

Small Cell ◽

Small Cell Lung ◽

Electronic Diary ◽

Patient Reported ◽

Paper And Pencil